Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections.

Daniel, Chris; Bhakta, Sanjib

Daniel, Chris; Bhakta, Sanjib.

Affiliation

Daniel C; Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Science, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK.
Bhakta S; Mycobacteria Research Laboratory, Institute of Structural and Molecular Biology, Department of Biological Science, Birkbeck, University of London, Malet Street, London WC1E 7HX, UK. Electronic address: s.bhakta@bbk.ac.uk.

Immunobiology ; 227(3): 152224, 2022 05.

Article in En | MEDLINE | ID: mdl-35533535

Subject(s)

Anti-Infective Agents; COVID-19 Drug Treatment; Mycobacterium tuberculosis; Tuberculosis; Anti-Infective Agents/therapeutic use; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Antitubercular Agents/pharmacology; Antitubercular Agents/therapeutic use; Humans; Immunomodulating Agents; Pandemics; Tuberculosis/drug therapy

Key words

Antimicrobial resistance (AMR); Carprofen; Drug repurposing; Mycobacterium tuberculosis (Mtb); NSAIDs; Non-tubercular mycobacteria (NTM); Tuberculosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / COVID-19 Drug Treatment / Anti-Infective Agents / Mycobacterium tuberculosis Type of study: Prognostic_studies Limits: Humans Language: En Journal: Immunobiology Year: 2022 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google